Number: 1 /

Gene Editing

Editor : Fatih Kocabas & Cihan Tastan
Assistant Editor : Medine Karadag-Alpaslan & Melek Onder Yuce
Publication Place : Istanbul, Turkey
Year-Number : 2020 - 1

Articles for this issue

The use of CRISPR/Cas9 gene editing system in the treatment of HBV infectioṅ, 1-7  
http://dx.doi.org/10.29228/genediting.40389
Medine Karadağ-Alpaslan
Gene editing studies for the treatment of AIDṠ, 8-20
http://dx.doi.org/10.29228/genediting.40387
Can Akpınaroğlu
Gene editing studies for the treatment of anemiȧ, 21-29
http://dx.doi.org/10.29228/genediting.40385
Fatih Kocabas -Batuhan Mert Kalkan, Gulcin Delal Nozhatzadeh, Fatih Kocabas
Alternative Therapy to Antibiotics: CRISPR-Cas antimicrobialṡ, 30-35
http://dx.doi.org/10.29228/genediting.41450
CIHAN TASTAN -Aysegul Ates, Cihan Tastan, Safak Ermertcan
CRISPR-Cas9 based gene editing technologies in induced pluripotent stem cellṡ, 36-41
http://dx.doi.org/10.29228/genediting.40391
Melek Yüce -Melek Yuce, Gulcin Delal Nozhatzadeh